Company Filing History:
Years Active: 2025
Title: Thomas Andrew Cornell: Innovator in Polymersome Technology
Introduction
Thomas Andrew Cornell is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biomedical engineering, particularly in the development of polymersomes. His innovative work focuses on encapsulating antigens for various medical applications.
Latest Patents
Cornell holds a patent for "Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof." This invention relates to polymersomes that contain a soluble encapsulated antigen, which can be a polypeptide, carbohydrate, polynucleotide, or combinations thereof. The patent also details methods for producing these encapsulated antigens and their applications in vaccines and treatments for cancer, autoimmune, or infectious diseases.
Career Highlights
Cornell is currently associated with Acm Biolabs Pte Ltd, where he continues to advance his research in polymersome technology. His work has the potential to revolutionize vaccine delivery and therapeutic strategies.
Collaborations
He collaborates with esteemed colleagues, including Madhavan Nallani and Fabien Decaillot, to further enhance the impact of his research.
Conclusion
Thomas Andrew Cornell's innovative work in polymersome technology exemplifies the intersection of science and medicine, paving the way for new therapeutic solutions. His contributions are vital in the ongoing quest to improve healthcare outcomes.